Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22576a6e59ca37178564f577bca9ee69 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-049 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
filingDate |
2002-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_800b802f2e5bd66a30d01ce33a0b81bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f02e22a38762461e8b0a7a62e75f975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c41a5767b3664bd00bb66fff4a6a90f |
publicationDate |
2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2464329-C |
titleOfInvention |
Stent coatings containing hmg-coa reductase inhibitors |
abstract |
Stents with coatings comprising a combination of a restenosis inhibitor comprising an HMG-CoA reductase inhibitor and a carrier. Also provided are methods of coating stents with a combination of an HMG-CoA reductase inhibitor and a carrier. A preferred example of a restenosis inhibitor is cerivastatin. The stent coatings have been shown to release restenosis inhibitors in their active forms. |
priorityDate |
2001-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |